U.S., March 18 -- ClinicalTrials.gov registry received information related to the study (NCT07478055) titled 'Biomarkers in Management of Post Partum Preeclampsia' on March 07.
Brief Summary: Participants are recruited for a research study about how lab values change following delivery in people with Preeclampsia with Severe Features. Preeclampsia with Severe Features means that the disease has impacted organs, causing high blood pressures, symptoms, or changes in lab values. Those with Preeclampsia with Severe Features receive magnesium sulfate after delivery.
The study is intended to learn how lab values change following delivery and to investigate how quickly participants get better from preeclampsia. Participation in this research wil...